Clinical Trial Detail

NCT ID NCT02955394
Title Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Anthony Elias
Indications

Her2-receptor negative breast cancer

Therapies

Fulvestrant

Enzalutamide + Fulvestrant

Age Groups: adult senior

Additional content available in CKB BOOST